DK0720483T3 - Anvendelse af væksthormon ved fremstilling af et medikament til behandling af iskæmisk hjerneödelæggelse og demens - Google Patents

Anvendelse af væksthormon ved fremstilling af et medikament til behandling af iskæmisk hjerneödelæggelse og demens

Info

Publication number: DK0720483T3
Authority: DK; Denmark
Prior art keywords: treatment; growth hormone; dementia; medicament; manufacture
Prior art date: 1993-09-21

Application number

DK94928538T

Other languages

English (en)

Inventor

Bengt Bengtsson

Olle G P Isaksson

Jan Johansson

Original Assignee

Sahltech Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-21

Filing date

1994-09-21

Publication date

2004-08-09

1994-09-21 Application filed by Sahltech Ab filed Critical Sahltech Ab

2004-08-09 Application granted granted Critical

2004-08-09 Publication of DK0720483T3 publication Critical patent/DK0720483T3/da

Links

102000018997 Growth Hormone Human genes 0.000 title abstract 3
108010051696 Growth Hormone Proteins 0.000 title abstract 3
239000000122 growth hormone Substances 0.000 title abstract 3
206010012289 Dementia Diseases 0.000 title 1
230000006931 brain damage Effects 0.000 title 1
231100000874 brain damage Toxicity 0.000 title 1
208000029028 brain injury Diseases 0.000 title 1
239000003814 drug Substances 0.000 title 1
230000000302 ischemic effect Effects 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 2
102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
102000004374 Insulin-like growth factor binding protein 3 Human genes 0.000 abstract 1
108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 abstract 1
102000013275 Somatomedins Human genes 0.000 abstract 1
210000001175 cerebrospinal fluid Anatomy 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK94928538T 1993-09-21 1994-09-21 Anvendelse af væksthormon ved fremstilling af et medikament til behandling af iskæmisk hjerneödelæggelse og demens DK0720483T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9303068A SE9303068D0 (sv)	1993-09-21	1993-09-21	New use
PCT/SE1994/000875 WO1995008345A1 (en)	1993-09-21	1994-09-21	Use of growth hormone for increasement of concentration of gh, igf-i and igfbp-3 in cerebrospinal fluid

Publications (1)

Publication Number	Publication Date
DK0720483T3 true DK0720483T3 (da)	2004-08-09

Family

ID=20391162

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94928538T DK0720483T3 (da)	1993-09-21	1994-09-21	Anvendelse af væksthormon ved fremstilling af et medikament til behandling af iskæmisk hjerneödelæggelse og demens

Country Status (13)

Country	Link
US (1)	US5736515A (da)
EP (1)	EP0720483B1 (da)
JP (1)	JPH09502973A (da)
AT (1)	ATE263573T1 (da)
AU (1)	AU683306B2 (da)
CA (1)	CA2168570C (da)
DE (1)	DE69433687T2 (da)
DK (1)	DK0720483T3 (da)
ES (1)	ES2218529T3 (da)
NZ (1)	NZ274025A (da)
PT (1)	PT720483E (da)
SE (1)	SE9303068D0 (da)
WO (1)	WO1995008345A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6514937B1 (en)	1997-02-25	2003-02-04	Celtrix Pharmaceuticals, Inc.	Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
US6015786A (en)	1997-02-25	2000-01-18	Celtrix Pharmaceuticals, Inc.	Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
US6025368A (en) *	1997-02-25	2000-02-15	Celtrix Pharmaceuticals, Inc.	Method for treating the symptoms of chronic stress-related disorders using IGF
CN1261158C (zh)	1998-09-03	2006-06-28	诺兰兹公司	生长激素在制备用于诱导神经保护作用的药剂中的应用
EP1149583A3 (en) *	2000-04-13	2001-11-14	Pfizer Products Inc.	Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
CA2532821A1 (en) *	2003-07-29	2005-02-17	Ares Trading S.A.	Use of human growth hormone in multiple system atrophy

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2974088A (en) *	1958-07-18	1961-03-07	Merck & Co Inc	Method of preparing growth hormone
US3118815A (en) *	1959-09-28	1964-01-21	Upjohn Co	Growth hormone and recovery thereof
CA1224432A (en) *	1982-08-17	1987-07-21	Gary N. Buell	Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield
US4521409A (en) *	1983-10-03	1985-06-04	Cornell Research Foundation, Inc.	Use of growth hormone to enhance ruminant mammary development
WO1986004308A1 (en) *	1985-01-28	1986-07-31	Seung Moon Park	Lighting apparatus for wheels of vehicles
US4670249A (en) *	1985-04-12	1987-06-02	International Minerals & Chemical Corp.	Growth-promoting compositions
US4786501A (en) *	1985-07-15	1988-11-22	International Minerals & Chemical Corp.	Cylindrical implants for the controlled release of growth hormones
IL79681A (en) *	1985-08-12	1991-06-10	Int Minerals & Chem Corp	Transition metal complexes of growth hormones and their prolonged release compositions
US4977140A (en) *	1985-08-23	1990-12-11	Eli Lilly And Company	Injectable sustained release formulation
IL79765A (en) *	1985-08-23	1992-02-16	Lilly Co Eli	Injectable sustained release formulations of bovine somatotropin
US4857506A (en) *	1987-01-12	1989-08-15	American Cyanamid Company	Sustained release growth hormone compositions for parenteral administration and their use
US4863736A (en) *	1987-03-16	1989-09-05	Monsanto Company	Somatotropin prolonged release
NZ223842A (en) *	1988-03-10	1991-07-26	Amgen Inc	Porcine growth hormone analogues, production using genetic engineering and compositions for promoting growth in mammals

1993
- 1993-09-21 SE SE9303068A patent/SE9303068D0/xx unknown
1994
- 1994-09-21 US US08/602,728 patent/US5736515A/en not_active Expired - Lifetime
- 1994-09-21 PT PT94928538T patent/PT720483E/pt unknown
- 1994-09-21 AT AT94928538T patent/ATE263573T1/de active
- 1994-09-21 DE DE69433687T patent/DE69433687T2/de not_active Expired - Lifetime
- 1994-09-21 WO PCT/SE1994/000875 patent/WO1995008345A1/en not_active Ceased
- 1994-09-21 JP JP7509721A patent/JPH09502973A/ja active Pending
- 1994-09-21 EP EP94928538A patent/EP0720483B1/en not_active Expired - Lifetime
- 1994-09-21 CA CA002168570A patent/CA2168570C/en not_active Expired - Fee Related
- 1994-09-21 NZ NZ274025A patent/NZ274025A/en not_active IP Right Cessation
- 1994-09-21 AU AU77933/94A patent/AU683306B2/en not_active Ceased
- 1994-09-21 ES ES94928538T patent/ES2218529T3/es not_active Expired - Lifetime
- 1994-09-21 DK DK94928538T patent/DK0720483T3/da active

Also Published As

Publication number	Publication date
AU683306B2 (en)	1997-11-06
DE69433687D1 (de)	2004-05-13
CA2168570C (en)	2009-04-07
PT720483E (pt)	2004-08-31
US5736515A (en)	1998-04-07
EP0720483B1 (en)	2004-04-07
SE9303068D0 (sv)	1993-09-21
ES2218529T3 (es)	2004-11-16
NZ274025A (en)	2005-03-24
ATE263573T1 (de)	2004-04-15
CA2168570A1 (en)	1995-03-30
DE69433687T2 (de)	2005-03-17
JPH09502973A (ja)	1997-03-25
EP0720483A1 (en)	1996-07-10
AU7793394A (en)	1995-04-10
WO1995008345A1 (en)	1995-03-30

Similar Documents

Publication	Publication Date	Title
DK0659083T3 (da)	2000-06-13	Forebyggelse og behandling af perifer neuropati
SE9604793L (sv)	1998-06-21	Nya Kristallmodifikationer
ATE185548T1 (de)	1999-10-15	Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
EP0476044A4 (en)	1992-07-01	Treating disorders by application of insulin-like growth factors and analogs
ATE204178T1 (de)	2001-09-15	Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE29729T1 (de)	1987-10-15	Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus.
ATE207352T1 (de)	2001-11-15	Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen
DK0436469T3 (da)	1995-04-03	Præparat og fremgangsmåde til behandling af osteoporose i pattedyr
PL320167A1 (en)	1997-09-15	2,2-dichloroalkanocarboxylic acids, method of obtaining them and therapeutic agents containing such compounds and their application in treating insulin immunity
DE69316013D1 (de)	1998-02-05	Verwendung von phosphinate zur behandlung der osteoporose
DK0589995T3 (da)	1999-07-19	Hidtil ukendte polypeptider og deres anvendelse
DK0720483T3 (da)	2004-08-09	Anvendelse af væksthormon ved fremstilling af et medikament til behandling af iskæmisk hjerneödelæggelse og demens
CA2074166A1 (en)	1991-08-14	Method for treating intestinal diseases
DE69301750D1 (de)	1996-04-18	Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
ATE157010T1 (de)	1997-09-15	Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
DE69332541D1 (de)	2003-01-16	Il-6 enthaltende pharmazeutische zusammensetzungen ihre verfahren zur behandlungder verbrauchenden hämorrhagischen thrombozythämie
DE69023006D1 (de)	1995-11-16	Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
DE69026087D1 (de)	1996-04-25	Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung
NO911237L (no)	1991-10-01	Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og kinolizidiner
ATE236652T1 (de)	2003-04-15	Igf-i and -ii zur behandlung von krankheiten im zentralnervensystem
SE9501773D0 (sv)	1995-05-15	New use
DK0538897T3 (da)	1997-08-25	Anvendelse af BMY 14802 ved behandling af angst hos benzodiazepinseponerede patienter
ATE44751T1 (de)	1989-08-15	Zusammensetzungen zum behandeln von ischaemie im gehirn.